Imatinib Terminated Phase N/A Trials for chronic Chronic myelogenous leukemia

IndicationsStatusPurposePhase
TerminatedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02146846Population Pharmacokinetics of Imatinib in CML Patients in Iran